GlassScriptPhysician profile
Sunil D Patel
NPI 1194410258
$1,716.08
in general payments reported to CMS, 2019-2025
11 companies · $291 in 2025
The $291 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $553 · 2024: $873 · 2025: $291.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607 · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.59 |
| Education | $109.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $408.32 | 2023-2025 | Austedo Xr, Uzedy, Austedo Xr |
| Abbvie INC. | $406.54 | 2023-2025 | |
| Corium, LLC | $151.24 | 2023-2024 | Azstarys, Azstarys |
| Lundbeck LLC | $147.69 | 2023-2025 | Rexulti |
| Alkermes, INC. | $130.66 | 2023-2025 | Lybalvi, Aristada |
| Axsome Therapeutics, INC. | $121.85 | 2024 | Auvelity |
| Idorsia Pharmaceuticals US INC | $120.30 | 2023 | Quviviq |
| Takeda Pharmaceuticals U.S.A., INC. | $95.35 | 2023-2025 | Trintellix |
| Neurocrine Biosciences, INC. | $84.30 | 2024-2025 | Ingrezza |
| Indivior INC. | $33.07 | 2024 | Perseris |
| Neos Therapeutics, LP | $16.76 | 2024 | Adzenys Xr-Odt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.